Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Outcomes in Diabetic and Nondiabetic Patients Treated With Everolimus- or Paclitaxel-Eluting Stents

Dean J. Kereiakes,Donald E. Cutlip,Robert J. Applegate,John Wang,Manejeh Yaqub,Poornima Sood,Xiaolu Su,Guoping Su,Naim Farhat,Ali Rizvi,Charles A. Simonton,Krishnankutty Sudhir, Gregg W. Stone

Journal of the American College of Cardiology（2010）

Cited 103|Views18
No score
Abstract
Conclusions In the SPIRIT IV randomized trial, EES compared with PES provided similar clinical outcomes in diabetic patients and superior clinical outcomes in nondiabetic patients at 1 year. (SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions; NCT00307047 )
More
Translated text
Key words
diabetes,drug-eluting stent(s),everolimus,major adverse cardiac event(s)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined